Sebastian Albers
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 25, 2024
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.Julia Caroline Michaeli, Thomas Michaeli, Dario Trapani
|Jul 31, 2024
Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|May 17, 2024
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|Nov 14, 2023
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|Oct 12, 2023
Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|Jul 24, 2023
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention.Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers
Pageof 2
